🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Robert LeBoyer

Stock Analyst at Noble Financial

(0.05)
# 4,883
Out of 5,162 analysts
432
Total ratings
24.7%
Success rate
-17.5%
Average return

Stocks Rated by Robert LeBoyer

Eledon Pharmaceuticals
Oct 27, 2026
Reiterated: Buy
Price Target: $10
Current: $2.03
Upside: +392.61%
NanoViricides
Oct 15, 2026
Reiterated: Buy
Price Target: $6
Current: $1.19
Upside: +404.20%
Ocugen
Sep 28, 2026
Reiterated: Buy
Price Target: $12
Current: $0.7392
Upside: +1,523.38%
MAIA Biotechnology
Sep 22, 2026
Reiterated: Buy
Price Target: $14
Current: $1.30
Upside: +976.92%
GeoVax Labs
Sep 17, 2026
Reiterated: Buy
Price Target: $240
Current: $1.99
Upside: +11,960.30%
Unicycive Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $50
Current: $3.57
Upside: +1,300.56%
Nutriband
Aug 12, 2026
Reiterated: Buy
Price Target: $15
Current: $4.82
Upside: +211.20%
NeuroSense Therapeutics
Aug 11, 2026
Reiterated: Buy
Price Target: $180
Current: $1.37
Upside: +13,038.69%
Gyre Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $20
Current: $4.34
Upside: +360.83%
Cadrenal Therapeutics
Jul 14, 2026
Reiterated: Buy
Price Target: $45
Current: $1.72
Upside: +2,516.28%
Reiterated: Buy
Price Target: $45
Current: $20.58
Upside: +118.66%
Reiterated: Buy
Price Target: $6 → $10
Current: $0.9769
Upside: +923.65%
Reiterated: Buy
Price Target: $12
Current: $0.839
Upside: +1,330.27%
Reiterated: Buy
Price Target: $8
Current: $3.20
Upside: +150.00%
Reiterated: Buy
Price Target: $70 → $37
Current: $2.82
Upside: +1,212.06%
Rated: Hold
Price Target: n/a
Current: $0.0811
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.7841
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.2425
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Reiterated: Buy
Price Target: $5
Current: $1.71
Upside: n/a
Reiterated: Buy
Price Target: $8 → $9
Current: $0.8385
Upside: n/a
Reiterated: Buy
Price Target: $0.73
Current: $0.03
Upside: n/a
Reiterated: Buy
Price Target: $20 → $20
Current: $0.7194
Upside: n/a
Reiterated: Buy
Price Target: $18 → $27
Current: $0.0001
Upside: n/a
Reiterated: Buy
Price Target: $6 → $15
Current: $3.89
Upside: n/a
Initiated Coverage: Buy
Price Target: $8
Current: $0.7068
Upside: n/a
Reiterated: Buy
Price Target: $6 → $14
Current: $1.37
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $4.44
Upside: n/a
Reiterated: Buy
Price Target: $6
Current: $0.4079
Upside: n/a
Reiterated: Buy
Price Target: $8
Current: $0.000001
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $8.27
Upside: n/a
Reiterated: Buy
Price Target: $5
Current: $0.3532
Upside: n/a
Initiated Coverage: Buy
Price Target: $30
Current: $1.06
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $3.29
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $2.82
Upside: n/a
Downgraded: Hold
Price Target: $17 → $1
Current: $16.23
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $2.75
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $1.37
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.9801
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.91
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Downgraded: Hold
Price Target: $54 → $41
Current: $17.83
Upside: n/a